Introduction
Subjects and methods
Parameter | APR(n = 38) | Edwards-MC3(n = 35) | DeVega(n = 34) |
---|---|---|---|
Age (years) | 42.56 ± 11.23 | 41.28 ± 11.13 | 43.45 ± 12.18 |
Male/Female | 18/20 | 17/18 | 17/17 |
Surface area (m2) | 1.58 ± 0.17 | 1.59 ± 0.18 | 1.60 ± 0.16 |
NYHA functional classification | |||
II (%) | 17 (45%) | 16 (46%) | 14 (41%) |
III (%) | 21 (55%) | 19 (54%) | 20 (59%) |
Sinus rhythm before operation (%) | 9 (24%) | 8 (23%) | 8 (24%) |
Atrial fibrillation (AF) to sinus rhythm during operation (%) | 29 (76%) | 27 (77%) | 26 (76%) |
Heart valve dysfunction | |||
Mitral valve (%) | 20 (53%) | 21 (60%) | 18 (53%) |
Aortic valve (%) | 0 | 0 | 0 |
Mitral valve and aortic valve (%) | 18 (47%) | 14 (40%) | 16 (47%) |
Degree of TR | |||
Mild (%) | 23 (61%) | 22 (63%) | 21 (62%) |
Severe (%) | 15 (39%) | 13 (37%) | 13 (38%) |
Number | Surface area (m2) | annulus size of the tricuspid (mm) |
---|---|---|
1 | 0.25 | 13.4 |
2 | 0.30 | 14.90 |
3 | 0.35 | 16.20 |
4 | 0.40 | 17.30 |
5 | 0.45 | 18.20 |
6 | 0.50 | 19.20 |
7 | 0.60 | 20.70 |
8 | 0.70 | 21.90 |
9 | 0.80 | 23.00 |
10 | 0.90 | 24.00 |
11 | 1.00 | 24.90 |
12 | 1.20 | 26.20 |
13 | 1.40 | 27.70 |
14 | 1.60 | 28.90 |
15 | 1.80 | 29.10 |
16 | 2.00 | 30.00 |
Follow-up study
Statistical analysis
Results
Parameters | APR group | Edwards-MC3 group | DeVega group | ||||||
---|---|---|---|---|---|---|---|---|---|
T = 0 | T = 2 mo | T = 24 mo | T = 0 | T = 2 mo | T = 24 mo | T = 0 | T = 2 mo | T = 24 mo | |
STR/STA(%) | 39 ± 12.22 | 8 ± 1.35 | 11 ± 2.42 | 37 ± 10.67 | 10 ± 2.48 | 12 ± 3.27 | 38 ± 12.12 | 12 ± 2.23 | 15 ± 4.16 |
DTAD (mm) | 36 ± 7.25 | 27 ± 1.16 | 28 ± 2.18 | 35 ± 6.11 | 28 ± 2.15 | 29 ± 2.79 | 35 ± 6.27 | 27 ± 1.38 | 32 ± 3.26 |
RAD (mm) | 47 ± 9.56 | 40 ± 7.69 a | 36 ± 5.38 | 46 ± 9.27 | 41 ± 7.33 | 36 ± 5.45 | 46 ± 9.56 | 42 ± 6.53 | 40 ± 5.38 |
RVD (mm) | 50 ± 10.12 | 45 ± 8.45 | 40 ± 7.22 | 49 ± 10.28 | 46 ± 8.27 | 40 ± 7.48 | 49 ± 10.23 | 45 ± 8.76 | 43 ± 6.56 |